Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosisJiří Reiniš, Thomas Reiberger, Oleksandr Petrenko et al.|Journal of Hepatology|2022Cited by 56
Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologiesPhilipp Königshofer, Thomas Reiberger, Benedikt Hofer et al.|Hepatology|2021Cited by 52
Nuclear receptors in liver fibrosisPhilipp Königshofer, Thomas Reiberger, Ksenia Brusilovskaya et al.|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2021Cited by 46
Evaluation of potential hepatic recompensation criteria in patients with <scp>PBC</scp> and decompensated cirrhosisBenedikt Hofer, Thomas Reiberger, Lukas Burghart et al.|Alimentary Pharmacology & Therapeutics|2024Cited by 31
FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Thomas Reiberger, Benedikt Hofer et al.|Hepatology International|2024Cited by 19